Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis

OBJECTIVE: This study evaluated work and activity impairment in patients with multiple sclerosis (MS) treated with ocrelizumab (OCR) versus other disease-modifying therapies (DMTs). METHODS: Data were obtained from the Adelphi Real World Disease Specific Programme for Multiple Sclerosis. Patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuberger, Edward E., Abbass, Ibrahim M., Jones, Eddie, Engmann, Natalie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140023/
https://www.ncbi.nlm.nih.gov/pubmed/33244713
http://dx.doi.org/10.1007/s40120-020-00224-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140023/
https://www.ncbi.nlm.nih.gov/pubmed/33244713
http://dx.doi.org/10.1007/s40120-020-00224-1

Ejemplares similares